Ra Pharma (RARX) PT Raised to $41 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Kennen MacKay raised the price target on Ra Pharma (NASDAQ: RARX) to $41.00 (from $18.00) on a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
